Forte Biosciences Income Statement (2016-2020) | FBRX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020
Revenue & cost
Revenue -0.49M-0.49M-0.50M-0.52M-0.60M0.01M0.01M0.01M0.01M0.01M18.01M0.01M0.01M0.01M0.01M0.01M-0.76M
Operating items
Research & Development 6.47M6.53M7.59M6.63M6.62M6.63M7.56M8.29M10.44M12.76M12.26M15.62M12.43M11.97M13.29M7.60M3.14M
Selling, General & Administrative 1.11M1.10M0.96M1.35M1.94M2.03M2.18M2.40M2.42M2.57M4.32M3.50M4.45M4.85M3.84M3.12M5.56M
Other Operating Expenses 0.00M-0.00M-0.00M-0.89M
Operating Expenses 7.58M7.63M8.54M7.99M8.56M8.66M9.75M10.70M12.86M15.34M16.58M19.12M16.88M16.82M17.13M10.71M8.70M
Operating Income -7.57M-7.62M-8.53M-7.97M-8.55M-8.65M-9.74M-10.69M-12.85M-15.33M1.43M-19.11M-16.87M-16.82M-17.12M-10.70M-8.70M
EBIT -7.57M-7.62M-8.53M-7.97M-8.55M-8.65M-9.74M-10.69M-12.85M-15.33M1.43M-19.11M-16.87M-16.82M-17.12M-10.70M-8.70M
Non-operating items
Non Operating Investment Income 0.05M0.01M-0.01M-0.00M-0.01M0.00M-0.03M-0.07M0.05M0.03M0.04M0.04M-0.01M-0.03M-0.01M
Interest & Investment Income 0.06M0.06M0.05M0.04M0.04M0.10M0.21M0.24M0.32M0.33M0.44M0.45M0.54M0.47M0.36M0.20M0.06M
Other Non Operating Income -0.03M-0.76M-0.30M-0.21M-0.30M-1.61M-1.58M
Non Operating Income -0.44M-0.42M-0.47M-0.46M-0.52M-0.41M-0.22M-0.15M-0.03M-0.76M-0.30M-0.21M-0.30M-1.61M-1.58M
Net income details
EBT -8.01M-8.07M-8.99M-8.46M-9.13M-9.04M-9.95M-10.84M-12.88M-16.09M1.13M-19.41M-17.08M-17.11M-18.73M-10.58M-9.39M
Tax Provisions 1.51M0.19M
Profit After Tax -8.01M-8.04M-9.00M-8.43M-9.07M-9.07M-9.95M-10.84M-12.88M-16.09M-0.38M-19.60M-17.08M-17.11M-18.73M-10.58M-10.28M
Income from Continuing Operations -8.01M-8.07M-8.99M-8.46M-9.13M-9.04M-9.95M-10.84M-12.88M-16.09M-0.38M-19.60M-17.08M-17.11M-18.73M-10.58M-9.39M
Consolidated Net Income -8.01M-8.07M-8.99M-8.46M-9.13M-9.04M-9.95M-10.84M-12.88M-16.09M-0.38M-19.60M-17.08M-17.11M-18.73M-10.58M-9.39M
Income towards Parent Company -8.01M-8.07M-8.99M-8.46M-9.13M-9.04M-9.95M-10.84M-12.88M-16.09M-0.38M-19.60M-17.08M-17.11M-18.73M-10.58M-9.39M
Net Income towards Common Stockholders -8.01M-8.07M-8.99M-8.46M-9.13M-9.04M-9.95M-10.84M-12.88M-16.09M-0.38M-19.60M-17.08M-17.11M-18.73M-10.58M-9.39M
Additional items
EPS (Basic) -3.64-3.66-4.09-3.83-4.11-0.56-0.50-0.55-0.65-0.81-0.02-0.96-0.74-0.72-0.78-0.45-0.43
Shares Outstanding (Weighted Average) 0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.06M0.06M0.06M0.06M0.06M0.06M0.45M
EBITDA -7.95M-8.03M-9.00M-8.44M-9.07M-9.07M-9.95M-10.87M-12.95M-16.04M-0.35M-19.60M-17.04M-17.08M-18.75M-10.62M-10.29M
Interest Expenses 0.50M0.51M0.51M0.53M0.62M0.49M0.43M0.39M0.35M1.09M0.74M0.75M0.75M0.76M1.97M0.33M0.76M